BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Allergy and Asthma Excellence Network - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Allergy and Asthma Excellence Network
X-ORIGINAL-URL:https://global-allergy.network
X-WR-CALDESC:Events for Global Allergy and Asthma Excellence Network
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20251001T170000
DTEND;TZID=Europe/Berlin:20251001T180000
DTSTAMP:20260422T123320
CREATED:20250912T112613Z
LAST-MODIFIED:20260420T083443Z
UID:9653-1759338000-1759341600@global-allergy.network
SUMMARY:ACARE MAD no. 15 | Modern HAE Prophylaxis at a Glance: 5 Years of Real-World Experience
DESCRIPTION:Date & Time \n\n\n\n\n\nACARE Make A Difference is a seventeen-part webinar series with a primary focus on the diagnostic evaluation of patients experiencing recurrent angioedema\, including those with hereditary angioedema (HAE)\, as well as the enhancement of therapy control and optimization.  \n\n\n\nThe overarching goal of this webinar series is to facilitate the provision of optimal therapy to all individuals afflicted with recurrent angioedema\, particularly those affected by HAE\, at the earliest possible stage. Throughout these webinars\, various topics will be explored\, including strategies to expedite the diagnosis process and reduce instances of misdiagnosis\, methods for family screening in HAE patients\, the implementation of closely monitored therapy control measures\, and guidance on the continual refinement of therapeutic approaches.  \n\n\n\nWelcome and Introduction – 5′ Prof. Dr. Markus Magerl Universitätsmedizin Berlin Institute of Allergology IFA & Fraunhofer\, ITMP Immunology and Allergology\, Berlin\, Germany  \n\n\n\nTALK 1| C1-INH in the Era of New Therapies: Patient Profiles and Practical Use Cases – 15′ Dr. Stefan Cimbollek Facultativo Especialista de Área en Hospital Universitario Virgen del Rocío\, Sevilla\, Spain  \n\n\n\nTALK 2 | Berotralstat in Daily Practice: Efficacy and Adherence in Real-World HAE Management – 15′ Assistant Professor Dr. Adil Adatia\, University of Alberta\, Edmonton\, Canada  \n\n\n\nTALK 3 | Lanadelumab in Real Life: A Long-Term perspective on Disease Control – 15′ Prof. Dr. Laurence Bouillet\, Clinique et de l’HAD\, CHU de Grenoble Alpes (CHUGA)\, Grenoble\, France  \n\n\n\nQ&A – 10′ All faculty\, moderated by Markus Magerl
URL:https://global-allergy.network/event/acare-mad-no-15-modern-hae-prophylaxis-at-a-glance-5-years-of-real-world-experience/
CATEGORIES:Educational event,Webinar
END:VEVENT
END:VCALENDAR